Advertisement

Acta Endoscopica

, 37:455 | Cite as

Les lésions néoplasiques et pré-néoplasiques superficielles de l’œsophage: diagnostic et bilan

  • E. Vaillant
État De L’art En Endoscopie Digestive
  • 29 Downloads

Conclusion

L’amélioration du pronostic du cancer épidermoïde de l’œsophage passe par un meilleur diagnostic des lésions néoplasiques superficielles chez les patients à risque. Une politique de dépistage chez ces patients en collaboration avec les spécialités qui sont au contact de la population cible est nécessaire.

Références

  1. 1.
    Benhamiche AM, Colonna M, Aptel I, Launoy G, Schaffer P, Arveux P, et al. Estimation de l’incidence des cancers du tube digestif par région. Gastroenterol Clin Biol 1999;23:1040–7.PubMedGoogle Scholar
  2. 2.
    Faivre J, EUROCARE Study Group. Variation in survival of patients with digestive tract cancers in Europe, 1978–1989. Eur J Cancer Prev 2001;10:173.PubMedCrossRefGoogle Scholar
  3. 3.
    Mariette C, Maurel A, Fabre S, Balon JM, Triboulet JP. Facteurs pronostiques préopératoires des cancers épidermoïdes de l’œsophage thoracique. Gastroenterol Clin Biol 2001;25:468–72.PubMedGoogle Scholar
  4. 4.
    Desoubeaux N, Le Prieur A, Launoy G, Maurel J, Lefevre H, Guillois JM, et al. Recent time trends in cancer of the oesophagus and gastric cardia in the region of Calvados in France, 1978–1995: a population based study. Eur J Cancer Prev 1999;8:479–86.PubMedCrossRefGoogle Scholar
  5. 5.
    Wang GQ, Jiao GG, Chang FB, Fang WH, Song JX, Lu N, et al. Long-term results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening. Ann Thorac Surg 2004;77:1740–4.PubMedCrossRefGoogle Scholar
  6. 6.
    Froelicher P, Miller G. The European experience with esophageal cancer limited to the mucosa and the submucosa. Gastrointest Endosc 1986;32:88–90.PubMedGoogle Scholar
  7. 7.
    Esaki M, Matsumoto T, Hirakawa K, Nakamura S, Umeno J, Koga H, et al. Risk factors for local recurrence of superficial esophageal cancer after treatment by endoscopic mucosal resection. Endoscopy 2007;41–5.Google Scholar
  8. 8.
    Dubuc J, Legoux JL, Winnock M, Seyrig JA, Barbier JP, Barrioz T, et al. Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 French endoscopy centers. Endoscopy 2006;38:690–5.PubMedCrossRefGoogle Scholar
  9. 9.
    Moschler O, Spahn TW, Middelberg-Bisping C, Grosse-Thie W, Christoph B, Kloeppel G, et al. Chromoendoscopy is a valuable tool for screening of high risk patients with head and neck cancer for early detection of esophageal cancer. Digestion 2006;73:160–6.PubMedCrossRefGoogle Scholar
  10. 10.
    The Paris Endoscopic classification of superficial Neoplastic Lesions: Esophagus, stomach and colon. Gastrointest Endosc 2003 suppl 58 (6).Google Scholar
  11. 11.
    Mori M, Adachi Y, Matsushima T, Matsuda H, Kuwano H, Sugimachi K. Lugol staining pattern and histology of esophageal lesions. Am J Gastroenterol 1993;88:701–5.PubMedGoogle Scholar
  12. 12.
    Pech O, May A, Gossner L, Rabenstein T, Manner H, Huijsmans J, et al. Curative endoscopic therapy in patients with early esophageal squamous-cell carcinoma or high-grade intraepithelial neoplasia. Endoscopy 2007;39:30–5.PubMedCrossRefGoogle Scholar
  13. 13.
    Meyer V, Burtin P, Bour B, Blanchi A, Cales P, Oberti F, et al. Endoscopic detection of early oesophageal cancer in a high-risk population: does Lugol staining improve videoendoscopy? Gastrointest Endosc 1997;45:480–4.PubMedCrossRefGoogle Scholar
  14. 14.
    Misumi A, Harada K, Murakami A, Arima K, Kondo H, Akagi M, et al. Role of Lugol dye endoscopy in the diagnostic of early esophageal cancer. Endoscopy 1990;22:12–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Fagundes RB, de Barros SG, Pütten AC, Mello ES, Wagner M, Bassi LA, et al. Occult dysplasia is disclosed by Lugol chromoendoscopy in alcoholics at high risk for squamous cell carcinoma of the esophagus. Endoscopy 1999;31:281–5.PubMedCrossRefGoogle Scholar
  16. 16.
    Hashimoto CL, Iriya K, Baba ER, Navarro-Rodriguez T, Zerbini MC, Eisig JN, et al. Lugol’s dye spray chromoendoscopy establishes early diagnosis of esophageal cancer in patients with primary head and neck cancer. Am J Gastroenterol 2005;100:275–82.PubMedCrossRefGoogle Scholar
  17. 17.
    Nakanishi Y, Ochiai A, Yoshimura K, Kato H, Shimoda T, Yamaguchi H, et al. The clinicopathologic significance of small areas unstained by Lugol’s iodine in the mucosa surrounding resected esophageal carcinoma: an analysis of 147 cases. Cancer 1998;82:1454–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Katada C, Muto M, Manabe T, Ohtsu A, Yoshida S. Local recurrence of squamous-cell carcinoma of the esophagus after EMR? Gastrointest Endosc 2005;61:219–25.PubMedCrossRefGoogle Scholar
  19. 19.
    Matsubara T, Yamada K, Nakagawa A. Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 2003;21:4336–41.PubMedCrossRefGoogle Scholar
  20. 20.
    Thésaurus de cancérologie. www.snfge.asso.fr/01-Bibliotheque/0G-Thesaurus-cancerologie/publication5/sommairethesaurus.asp.Google Scholar
  21. 21.
    May A, Günter E, Roth F, Gossner L, Stolte M, Vieth M, et al. Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial. Gut 2004;53:634–40.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • E. Vaillant
    • 1
  1. 1.Lille

Personalised recommendations